A Single-Cell-Derived Proliferative Signature Is Associated With Progression-Free Survival During Immunotherapy and Sunitinib Treatment in Clear Cell Renal Cell Carcinoma.

Li Z, Xing S, Zeng S, Zhang Y, Li Y, Liu Q

Open source

DOI
10.1155/genr/4050985
Published
2026
Container
Genetics research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/genr/4050985,
  title = {A Single-Cell-Derived Proliferative Signature Is Associated With Progression-Free Survival During Immunotherapy and Sunitinib Treatment in Clear Cell Renal Cell Carcinoma.},
  author = {Li Z and Xing S and Zeng S and Zhang Y and Li Y and Liu Q},
  year = {2026},
  journal = {Genetics research},
  doi = {10.1155/genr/4050985},
  url = {https://doi.org/10.1155/genr/4050985}
}

RIS

TY  - JOUR
TI  - A Single-Cell-Derived Proliferative Signature Is Associated With Progression-Free Survival During Immunotherapy and Sunitinib Treatment in Clear Cell Renal Cell Carcinoma.
AU  - Li Z
AU  - Xing S
AU  - Zeng S
AU  - Zhang Y
AU  - Li Y
AU  - Liu Q
PY  - 2026
JO  - Genetics research
DO  - 10.1155/genr/4050985
UR  - https://doi.org/10.1155/genr/4050985
ER  - 

APA

Z, L., S, X., S, Z., Y, Z., Y, L., & Q, L. (2026). A Single-Cell-Derived Proliferative Signature Is Associated With Progression-Free Survival During Immunotherapy and Sunitinib Treatment in Clear Cell Renal Cell Carcinoma.. Genetics research. https://doi.org/10.1155/genr/4050985

Source records